BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230504T080000
DTEND;TZID=America/New_York:20230504T120000
DTSTAMP:20230501T154445Z
CREATED:20230501T153634Z
LAST-MODIFIED:20230501T154445Z
UID:57174-1683187200-1683201600@globalbiodefense.com
SUMMARY:Prioritizing Actions for Epidemic and Pandemic Preparedness
DESCRIPTION:The Prioritizing Actions for Epidemic and Pandemic Preparedness Virtual Symposium will be held 4 May and 18 May 2023. \nThis first session will be held from 8:00am-12:00pm ET on 4 May 2023 and the second session from 8:00 am-12:00pm ET on 18 May 2023. \nThe purpose of this symposium is to convene global health planning stakeholders\, including those in government and academia\, and across health- and non-health sectors\, to strengthen the capacity for evidence-based prioritization of global health capabilities. Objectives of this meeting are the following: \n\nReview assessment tools and how\, independently and together\, they relate to national action planning.\nGain insight into how countries and organizations currently select priorities in funding for epidemic prevention\, detection\, and response.\nAssess evidence for effective prioritization approaches to building disease surveillance and risk communication capabilities.\nIdentify governance structures that can support robust and reliable systems for global health investments.\n\nAGENDA\nPolitical and Economic Context for Sustainable International Epidemic Preparedness: International Governance and Finance (Session 1)\nThe goal of this forward-looking discussion is to highlight critical needs\, challenges\, and gaps in international and national governance and financing for developing and maintaining critical capabilities needed to prevent\, detect\, and respond to future epidemics. \nModerator: Dr. Mercy Mwangangi\, AMREF Kenya \nSpeakers:\nRaj Panjabi\, White House National Security Council\nSara Hersey\, World Health Organization Health Emergencies\nPriya Basu\, Pandemic Fund Secretariat\, World Bank Group\nSaul Walker\, Coalition for Epidemic Preparedness Innovations (CEPI) \nPolitical and Economic Context for Sustainable International Epidemic Preparedness: Regional and Country Efforts and Building Trust (Session 2)\nThe goal of this forward-looking discussion is to highlight critical needs\, challenges\, and gaps in science\, public health\, and health security for strengthening and maintaining critical capabilities needed to prevent\, detect\, and respond to future epidemics. \nModerator: Dr. Mercy Mwangangi\, AMREF Kenya \nSpeakers:\nAyoade Alakija\, African Vaccine Delivery Alliance\, Pre-recorded Video\nIrma Makaliano\, University of the Philippines\nDuncan Selbie\, International Association of National Public Health Institutes\nJailson Correia\, Instituto de Medicina Integral Professor Fernando Figueira\nWessam Mankoula\, Africa Centers for Disease Control \nAction Groups Preview \n\nSituational Awareness in the Context of Health and Diseases: Larry Brilliant\, Pandefense Advisory\nBuilding Trust\, Transparency\, and Risk Communication Capabilities: Richard Garfield\, US Centers for Disease Control and Prevention\nStrengthening Global Health Security through Strong Country-Level Infrastructure for Effective Governance\, Financing\, and Accountability: Julie Wahl\, Resolve to Save Lives\nGlobal Health Capacity and Functionality Assessment: Jessica Petrillo\, US Agency for International Development\nCountries’ and Organizations’ Experiences in Preparedness and Response Planning: Erwin Calgua\, Universidad de San Carlos de Guatemala\n\nPlease visit the National Academies’ Prioritizing Actions for Epidemic and Pandemic Preparedness Virtual Symposium page for more information and to register for virtual attendance.
URL:https://globalbiodefense.com/event/prioritizing-actions-for-epidemic-and-pandemic-preparedness/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230507
DTEND;VALUE=DATE:20230511
DTSTAMP:20230422T170026Z
CREATED:20230421T232418Z
LAST-MODIFIED:20230422T170026Z
UID:57016-1683417600-1683763199@globalbiodefense.com
SUMMARY:ABRF 2023 Annual Meeting | Association of Biomolecular Resource Facilities
DESCRIPTION:The Annual Meeting of the Association of Biomolecular Resource Facilities (ABRF 2023) will be held 7-10 May 2023 in Boston\, Massachusetts. \nHighlighted topics and presentations include: \n\nBusiness Skills for Core Facility Directors\, Managers and Administrators\nAdvancing Single Cell in Core Laboratories\nImplementing Spatial Transcriptomics in Core Facilities\nUsing R/R-Studio for reproducible data analysis and visualization\nSpatial Biology for Shared Research Laboratories\nGenome Editing Cores and Best Practices\nSample Preparation for Single Cell Genomics\nNon-Biological Core Facilities and Their Place within ABRF\nDigital PCR–applications\, challenges\, and use in a core setting\nNew Sequencers and Evolving Next Generation Sequencing Landscape\nWhat Do We Hand Over When an Analysis Is Finished? A spectrum-style discussion\nCell Sorting Technology Acquisition in the SRL: Evaluation\, Integration and Deployment to Users\nUpdates from the Microbiome and Metagenomics\, Genome Engineering\, and Genomics Research Groups\n\nPlease visit the ABRF 2023 Annual Meeting site for more information and to register.
URL:https://globalbiodefense.com/event/abrf-2023-annual-meeting-association-of-biomolecular-resource-facilities/
LOCATION:Sheraton Boston Hotel\, 39 Dalton Street\, Boston\, MA\, 02199\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230511T154500
DTEND;TZID=America/New_York:20230511T170000
DTSTAMP:20230421T195422Z
CREATED:20230421T195422Z
LAST-MODIFIED:20230421T195422Z
UID:56995-1683819900-1683824400@globalbiodefense.com
SUMMARY:Collaborating on Culture in the New Era of Smarter Food Safety
DESCRIPTION:Live from the Food Safety Summit: Measure What You Treasure\nMay 11\, 2023\, from 3:45 pm 5:00 pm ET \nThe upcoming webinar will focus on the importance of assessing food safety culture in an organization. \nGuest speakers include: \n\nDonald A. Prater\, DVM\, Acting Director\, Office of Food Policy and Response\, FDA\nConrad Choiniere\, PhD\, Director\, Office of Analytics and Outreach\, Center for Food Safety and Applied Nutrition\, FDA\nLone Jespersen\, Principal and Founder\, Cultivate SA\nVanessa Coffman\, Director\, Alliance to Stop Foodborne Illness\nBrian Perry\, Executive Food Safety & Quality Leader\, TreeHouse Foods\, Inc\nKarleigh Bacon\, Director of U.S. Supply Chain Food Safety\, Science & Regulatory\, McDonald’s Corporation\nPhilip Bronstein\, Ph.D.\, Assistant Administrator\, Office of Field Operations\, Food Safety and Inspection Service\, Food Safety and Inspection Service\, USDA\n\nThe U.S. Food and Drug Administration and Stop Foodborne Illness\, a non-profit public health organization\, are collaborating on a webinar series that explores food safety culture\, one of the core elements in FDA’s New Era of Smarter Food Safety initiative. \nThe New Era of Smarter Food Safety blueprint states that dramatic improvements in reducing the burden of foodborne illness cannot be made without doing more to influence the beliefs\, attitudes\, and\, most importantly\, the behaviors of people and the actions of organizations. \nPlease visit the FDA’s Collaborating on Culture in the New Era of Smarter Food Safety event page for more information and to register to attend this virtual event.
URL:https://globalbiodefense.com/event/collaborating-on-culture-in-the-new-era-of-smarter-food-safety/
CATEGORIES:Government Hosted
LOCATION:https://zoom.us/webinar/register/WN_uMaG_U92TLGqb-2bTozXSw#/registration
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230518T080000
DTEND;TZID=America/New_York:20230518T120000
DTSTAMP:20230501T154139Z
CREATED:20230501T153817Z
LAST-MODIFIED:20230501T154139Z
UID:57177-1684396800-1684411200@globalbiodefense.com
SUMMARY:Prioritizing Actions for Epidemic and Pandemic Preparedness
DESCRIPTION:The Prioritizing Actions for Epidemic and Pandemic Preparedness Virtual Symposium will be held 18 May 2023. \nThis is the second of two sessions. The purpose of this symposium is to convene global health planning stakeholders\, including those in government and academia\, and across health- and non-health sectors\, to strengthen the capacity for evidence-based prioritization of global health capabilities. \nObjectives of this meeting are the following: \n\nReview assessment tools and how\, independently and together\, they relate to national action planning.\nGain insight into how countries and organizations currently select priorities in funding for epidemic prevention\, detection\, and response.\nAssess evidence for effective prioritization approaches to building disease surveillance and risk communication capabilities.\nIdentify governance structures that can support robust and reliable systems for global health investments.\n\nAGENDA\nHealth Security Action Areas: Issues and Opportunities\nThe goals of these discussions are to review success and failures\, use of assessment tools\, identify outstanding gaps and determine critical areas for action to sustainably improve capabilities in three areas. \nSituational Awareness in the Context of Health and DiseasesThe goal of this discussion is to re-set expectations at a higher-level of what can be done to keep both public health and the general public aware of changes in disease risks as early as possible by combining many current surveillance systems with new sources of disease data to form near real time awareness of constantly changing disease risks. \nTopics covered in this discussion include: \n\nCurrent tools for disease surveillance and the international tools used to evaluate the effectiveness of these systems\nRoutine methods and genetic surveillance for assessing situational awareness\nRecent innovations in detection in detection of novel diseases and use of closer-to-real-time monitoring of critical changes in endemic disease\nRecent experience including new types of disease surveillance and combinations of traditional and new methods to improve situational awareness\nIntegration of surveillance tools to realize near-real-time situational awareness\n\nModerator: Larry Brilliant\, Pandefense Advisory \nDiscussants:Mark Smolinski\, Ending PandemicsPatipat Keng Susumpow\, Opendream CoChanne Suy\, Co–Founder\, Kawsang \nBuilding Trust\, Transparency\, and Risk Communication Capabilities\nThe goal of this discussion is to review existing guidance and frameworks for risk communication\, highlighting approaches that are particularly effective for communicating risk about epidemics and describing approaches that have been demonstrated to be less effective or ineffective in communicating risks. \nModerator: Richard Garfield\, U.S. Centers for Disease Control and Prevention \nDiscussants:\nKatelyn Jetelina\, Your Local Epidemiologist\nRania Elessawi\, UNICEF\nBaruch Fischhoff\, Carnegie Mellon University \nStrengthening Global Health Security through Strong Country-Level Infrastructure for Effective Governance\, Financing\, and Accountability\nA country’s performance during an infectious disease outbreak is only as strong as its ability to leverage multisectoral partnerships; coordinate at national\, subnational and community levels; and continuously develop and strengthen health and public health system capacity to prevent and respond to outbreaks. \nThe goal of this discussion is to examine how improving global health security begins at the country-level and how countries can strengthen their public health architecture for epidemic preparedness and response through effective mechanisms for governance\, financing\, and accountability. This group will focus on the following questions: \n\nHow might countries /organizations ensure effective multisectoral governance at country-level?\nHow might countries /organizations foster accountability among partners and stakeholders that drives continuous quality improvement and well-prioritized investments?\n\nModerators\nJulie Wahl\, Resolve to Save Lives\nGisela Scaglia\, Former Member of Parliament Argentina \nDiscussants\nAminu Magashi Garba\, Africa Budget Network\nImmaculate Nabukenya\, Makerere University\nAbrham Ejigu – Senior Project Manager\, Resolve to Save Lives\, Ethiopia \nCross-Cutting Action Areas: Issues and Opportunities\nThe goals of these discussions are to review success and failures\, use of assessment tools\, identify outstanding gaps and determine critical areas for action to sustainably improve capabilities in three overarching areas \nGlobal Health Security Capacity and Functionality Assessment\nTimely access to quality\, actionable data underpins effective prioritization of investments to address GHS capacity and functionality gaps. The goal of this session is to discuss and identify critical needs\, challenges\, gaps\, and\nopportunities to improve GHS capacity and functionality assessment tools\, their use\, and the use of the data they generate to inform decision making on strengthening and maintaining critical capabilities needed to prevent\, detect\, and respond to any future epidemics. Participants will discuss the following issues: \n\nIdentify challenges in the use of existing tools (including accessibility) and opportunities to improve them.\nIdentify opportunities to improve interoperability\, interconnectedness\, and integration of assessment tools and data.\nIdentify opportunities to improve linkages between capacity/capability guidance and assessment tools.\nParticipants will have a worksheet to contribute to prior to and following the discussion.\nParticipants will use Jamboard to add suggested actions for addressing identified gaps.\n\nModerators\nAamer Ikram\, National Institutes of Health Pakistan\nJessica Petrillo\, U.S. Agency for International Development \nDiscussants:\nAnne Liu\, Gates Ventures\nDr. Magda Robalo Correia e Silva\, Institute for Global Health and Development\nCharles Bebay\, ECTAD Regional Manager for Eastern and Southern Africa\,\nFood and Agriculture Organization \nCountries’ and Organizations’ Experiences in Preparedness and Response Planning\nThe goal of this discussion is to identify lessons and best practices for preparedness and response at the national level\, and identify actions on policy and practice for improving preparedness and planning for the next pandemic by learning from what went well and what went less well in national contexts. \nExamples exist of countries on good planning practices to address the SARS-CoV-2 pandemic. These countries have observed strong and weak points in the national system through systematic monitoring and evaluation (M&E) tools (e.g.\, IHR\, Joint External Evaluation\, Universal Health and Preparedness Review). Before engaging in discussion about these topics\, participants will hear from two examples of countries from different perspectives. This discussion will focus on the following questions: \n\nWhat are the actual practices in a term of multisectoral approach that the country is adopting as a result of learning in this symposium from the M&E tool?\nWhat’s the nature of the reinforcement process of preparedness and response planning at the national level?\n\nParticipants will be asked to suggest approaches and actions to guide each country’s decision to implement and strengthen the use of their preparation and response plans with academia\, donors\, and private partners. \nModerators\nSoawapak Hinjoy\, Department of Disease Control\, Ministry of Health\, Thailand\nErwin Humberto Calgua Guerra\, Universidad de San Carlos de Guatemala\nArminder Kaur Deol\, Coalition of Epidemic Preparedness Innovations \nDiscussants:\nJeffery Cutter\, Ministry of Health Singapore\nAli Ardalan\, Health Systems in Emergencies Lab\, World Health Organization\nRegional Officer for the Eastern Mediterranean \nPlease visit the National Academies’ Prioritizing Actions for Epidemic and Pandemic Preparedness Virtual Symposium page for more information and to register for virtual attendance.
URL:https://globalbiodefense.com/event/prioritizing-actions-for-epidemic-and-pandemic-preparedness-2/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230518T083000
DTEND;TZID=America/New_York:20230518T173000
DTSTAMP:20230421T194600Z
CREATED:20230421T194600Z
LAST-MODIFIED:20230421T194600Z
UID:56993-1684398600-1684431000@globalbiodefense.com
SUMMARY:VRBPAC Meeting on Pfizer's ABRYSVO Respiratory Syncytial Virus Vaccine
DESCRIPTION:Vaccines and Related Biological Products Advisory Committee May 18\, 2023 Meeting Announcement \nOn 18 May 2023\, the committee will meet in open session to discuss and make recommendations on the safety and effectiveness of ABRYSVO (Respiratory Syncytial Virus Vaccine)\, manufactured by Pfizer Inc.\, with a requested indication\, in Biologics License Application (BLA) 125768 (STN 125768/0)\, for the prevention of lower respiratory tract disease and severe lower respiratory tract disease caused by RSV in infants from birth through 6 months of age by active immunization of pregnant individuals. \nAdvisory committees provide independent expert advice to the FDA on broad scientific topics or on certain products to help the agency make sound decisions based on the available science. Advisory committees make non-binding recommendations to the FDA\, which generally follows the recommendations but is not legally bound to do so. Please see\, “Advisory Committees Give FDA Critical Advice and the Public a Voice\,” for more information. \nMeeting Materials\nFDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its website prior to the meeting\, the background material will be made publicly available on FDA’s website at the time of the advisory committee meeting. Additional materials will be posted on FDA’s website after the meeting. \nMaterials for this meeting will be available at the Vaccines and Related Biological Products Advisory Committee meetings main page. \nThe meeting will include slide presentations with audio components to allow the presentation of materials in a manner that most closely resembles an in-person advisory committee meeting. \nPublic Participation Information\nInterested persons may present data\, information\, or views\, orally or in writing\, on issues pending before the committee. FDA is establishing a docket for public comment on this meeting. \nThe Docket Number is FDA-2023-N-1338 \nComments received on or before May 11\, 2023\, will be provided to the committee. Comments received after May 11\, 2023\, and by May 17\, 2023\, will be taken into consideration by FDA. In the event the meeting is canceled\, FDA will continue to evaluate any relevant applications or information\, and consider any comments submitted to the docket\, as appropriate. \nPlease visit the VRBPAC Meeting Announcement page for more information.
URL:https://globalbiodefense.com/event/vrbpac-meeting-on-pfizers-abrysvo-respiratory-syncytial-virus-vaccine/
CATEGORIES:Government Hosted
LOCATION:https://www.youtube.com/watch?v=NXVMILYvocM
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230524T090000
DTEND;TZID=America/New_York:20230524T140000
DTSTAMP:20230421T193224Z
CREATED:20230421T193224Z
LAST-MODIFIED:20230421T193224Z
UID:56991-1684918800-1684936800@globalbiodefense.com
SUMMARY:Update on Field Alert Reports (FAR) and Biological Product Deviation Reports (BPDR)
DESCRIPTION:FDA CDER Office of Pharmaceutical Quality is offering a five-hour webinar to discuss reporting requirements and expectations for Field Alert Reports (FAR) and Biological Product Deviation Reports (BPDR). The statutory reporting requirements are found in 21 CFR 314.81 (for FAR) and 21 CFR 600.14 (for BPDR). FDA will share how it assesses these reports and how they support risk-based decisions in a variety of contexts. These reports provide an early warning signal to the agency that a marketed product may harm patients due to a deviation or incident that has occurred. \nThis webinar will present FDA expectations for conducting root cause analysis and then implementing and assessing effectiveness of corrective action and preventive action plans (CAPAs) to mitigate the severity and probability of harm. Attendees will learn how the agency is integrating advanced analytics (e.g.\, machine learning and natural language processing) to innovate processes and facilitate proactive approaches to quality risk management. FDA will also share some common reporting errors as well as best practices for report submission. \nTOPICS COVERED\n\nPost-market reporting (FARs and BPDRs) requirements and expectations – who is responsible for reporting\, how do you report\, and what happens if they are not reported\nFDA’s use of post-market quality defect reports to support risk-based decisions\nThe parameters of OPQ’s assessment for FARs and BPDRs (i.e.\, how are they assessed and what is the overall business process OPQ manages\nThe integration of advanced analytics into OPQ’s post-market quality defect report program\n\nLEARNING OBJECTIVES\n\nWhat are the post-market reporting requirements and expectations for application holders and manufacturers.\nHow does FDA manage and assess the reports.\nWhat to expect regarding follow-ups and engagement from FDA after submitting a report.\nHow does FDA utilize FARs/BPDRs to support regulatory decisions (e.g.\, surveillance inspection prioritization\, pre-approval/pre-license inspections\, regulatory flexibility\, etc.).\nHow does FDA integrate FARs/BPDRs into their overall assessment on the state of pharmaceutical quality.\nHow is FDA innovating processes for managing FARs/BPDRs with the integration of advanced analytics.\n\nINTENDED AUDIENCE\n\nNDA\, ANDA\, BLA applicant holders\nGeneric and New Drug Pharmaceutical manufacturers (including CDMOs)\nContract Testing Laboratories\nRegulatory Affairs professionals supporting post-marketing reporting requirements\nQuality Assurance and Quality Control professionals\nConsultants supporting pharmaceutical manufacturers\nForeign Regulators\n\nFDA RESOURCES\n\n21 CFR 314.81\n21 CFR 600.14\nField Alert Reports\nCDER – Biological Product Deviations\n\nCONTINUING EDUCATION\nReal-time attendance is required for the certificate of attendance which can be used in support of CEs for the following professional organizations. Certificates are only available during the two weeks post-event. \nThis webinar has been: \n\npre-approved by RAPS as eligible for a maximum of 12 credits for a two day event (appropriate to real-time attendance) towards a participant’s RAC recertification upon full completion.\npre-approved by SOCRA who accepts documentation of candidate participation in continuing education programs for re-certification if the program is applicable to clinical research regulations\, operations or management\, or to the candidate’s clinical research therapeutic area.\npre-approved by SQA as eligible for 1 non-GCP or non-GLP unit for every 1 hour of instructional time towards a participant’s RQAP re-registration\napproved by ACRP for continuing education in clinical research. ACRP will provide 1 ACRP contact hour for every 45-60 minutes of qualified material.\n\nPlease visit the FDA’s Update on Field Alert Reports (FAR) and Biological Product Deviation Reports (BPDR) meeting page for more information and to register to attend virtually.
URL:https://globalbiodefense.com/event/update-on-field-alert-reports-far-and-biological-product-deviation-reports-bpdr/
CATEGORIES:Government Hosted
LOCATION:
END:VEVENT
END:VCALENDAR